MTM(SH:688029)2025-04-28 15:05Financial Performance - The company's operating revenue for Q1 2025 was CNY 699,156,940.30, representing a 12.75% increase compared to CNY 620,078,643.58 in the same period last year[4] - Net profit attributable to shareholders was CNY 160,936,939.70, up 12.18% from CNY 143,464,442.08 year-on-year[4] - The basic and diluted earnings per share were both CNY 0.86, representing a 13.16% increase from CNY 0.76 in the same period last year[4] - Net profit for Q1 2025 was ¥167,162,271.01, representing a 13.36% increase from ¥147,454,778.74 in Q1 2024[19] - Basic and diluted earnings per share for Q1 2025 were both ¥0.86, compared to ¥0.76 in Q1 2024[20] - Other comprehensive income after tax for Q1 2025 was ¥9,159,697.47, compared to a loss of ¥4,059,448.59 in Q1 2024[20] Cash Flow - The net cash flow from operating activities increased by 26.63%, reaching CNY 70,567,097.65 compared to CNY 55,725,577.73 in the previous year[4] - Cash generated from operating activities in Q1 2025 was ¥739,607,987.83, an increase from ¥661,872,530.42 in Q1 2024[21] - The net cash flow from operating activities was $70,567,097.65, an increase of 26.67% compared to $55,725,577.73 in the previous period[22] - The ending balance of cash and cash equivalents was $1,854,972,301.38, up from $911,582,949.17 in the previous period[23] Assets and Liabilities - The total assets at the end of the reporting period were CNY 4,931,235,488.59, reflecting a 3.17% increase from CNY 4,779,606,949.81 at the end of the previous year[5] - The company's current assets totaled RMB 3,223,440,427.41, down from RMB 3,320,779,018.70 at the end of 2024, indicating a decrease of approximately 2.9%[14] - The company's total liabilities decreased to RMB 707,067,941.17 from RMB 806,488,497.71, representing a reduction of approximately 12.3%[15] - The total liabilities decreased to ¥788,040,181.59 in the latest report from ¥880,243,496.13[16] - Total equity attributable to shareholders increased to ¥3,994,462,762.08 from ¥3,826,092,661.23[16] Research and Development - Research and development expenses totaled CNY 38,058,328.95, a 23.09% increase from CNY 30,920,136.25, accounting for 5.44% of operating revenue[5] - Research and development expenses for Q1 2025 were ¥38,058,328.95, up from ¥30,920,136.25 in Q1 2024, indicating a focus on innovation[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,313[8] - The largest shareholder, Shenzhen Zhongke Investment Co., Ltd., held 22.23% of the shares, totaling 41,752,818 shares[8] Non-Recurring Items - The company reported a non-recurring loss of CNY 136,954.02, primarily due to various non-operating income and expenses[6] Investments - The long-term equity investments increased to RMB 63,442,686.57 from RMB 59,795,713.32, showing an increase of about 6.8%[14] - The company reported a significant increase in investment income to ¥3,567,616.18 from ¥2,803,690.30 year-over-year[19] Inventory and Receivables - The inventory value increased to RMB 615,988,795.17 from RMB 536,582,311.14, reflecting a growth of about 14.8%[14] - The company's accounts receivable rose to RMB 523,438,259.11 from RMB 434,035,954.27, marking an increase of about 20.6%[14] Employee Compensation - The company reported a decrease in employee compensation payable from RMB 144,064,326.06 to RMB 72,217,987.56, a reduction of approximately 50.1%[15] - Payments to employees amounted to $270,913,522.63, slightly up from $262,629,113.36 in the previous period[22] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect the financial statements[23]